Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children.

[1]  G. von Bernuth,et al.  Histamine liberation related to cardiopulmonary bypass in children: possible relation to transient postoperative arrhythmias. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  C. Osmer,et al.  Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin. , 1995, The Annals of thoracic surgery.

[3]  G. von Bernuth,et al.  Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. , 1993, The Journal of thoracic and cardiovascular surgery.

[4]  T. Evans,et al.  Humoral and cellular activation in a simulated extracorporeal circuit. , 1993, The Annals of thoracic surgery.

[5]  M. Jochum,et al.  Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations , 1993 .

[6]  T. Treasure,et al.  Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. , 1993, The Annals of thoracic surgery.

[7]  S. Westaby.  Aprotinin in perspective. , 1993, The Annals of thoracic surgery.

[8]  S Westaby,et al.  Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[9]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[10]  O. Ratnoff,et al.  Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol) , 1992, The Journal of laboratory and clinical medicine.

[11]  J. E. Doran,et al.  Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[12]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[13]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[14]  W. van Oeveren,et al.  Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. , 1987, The Annals of thoracic surgery.

[15]  C. Hack,et al.  SERUM LEVELS OF INTERLEUKIN-6 AND ACUTE PHASE RESPONSES , 1987, The Lancet.

[16]  Reid Kb,et al.  Activation and control of the complement system. , 1986 .

[17]  J. Hogg,et al.  The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. , 1985, The Journal of thoracic and cardiovascular surgery.

[18]  H. Fritz,et al.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. , 1983, Arzneimittel-Forschung.

[19]  A. Burden,et al.  The effect of protease inhibitors on leucocyte migration inhibition to tuberculin extract (P.P.D.). , 1978, Immunology.

[20]  J. Delâge,et al.  The enhancement of the haemolytic activity of the first component of complement by trasylol. , 1976, Immunology.